Stay updated on Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-11-02T23:47:44.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A banner announces an NIH-wide transition notice about using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T23:52:34.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-20T00:26:43.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T05:56:36.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page transitioned from a 403 error to displaying the ClinicalTrials.gov study record for NCT03945773, restoring access to the study details and navigation.
    Difference
    0.5%
    Check dated 2026-09-29T00:17:08.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating restricted access to the study record rather than listing study details or results.
    Difference
    18%
    Check dated 2026-09-22T00:18:30.000Z thumbnail image

Stay in the know with updates to Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.